Traditional Complementary and Alternative Medicine (CAM) Therapy in the Treatment of HIV/AIDS

PHASE3CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

February 27, 2012

Primary Completion Date

February 27, 2017

Study Completion Date

February 27, 2017

Conditions
HIV Infections
Interventions
DRUG

"Kallunk oxide (Immunotherapy) "

"The study is assigned Arm 1 above 450 cu/mm\^3 baseline CD + T cells. HIV type-1 subjects will receive one drug, a daily regimen of Kallunk oxide(Immunotherapy) + Long Pepper, that is a combination of a traditional alternative medicine (Complementary and Alternative Medicine CAM) as Kallunk oxide and appropriate drug carrier antidote. The drug assigns to 5 mg Kallunk oxide molecules with1995 mg Antidote( This antidote was used as a carrier of Kallunk oxide molecules), respectively, for children and adults. Dosage: 2000 mg for children and adults. This powder form sample size product will be administered once daily dose on 7 days treatment. The Botanical name of the antidote is Piper Longum."

Trial Locations (3)

414002

Project Site Office, Hospital of Integrated Research Site HIRS(New), Ahammed Nagar, Mathura Nagar, Bhingar- PO, Mumbai

678553

Project Site Office, Near Sivan Kovil, Nallepily, Hospital of Integrated Research Site HIRS [new]), Palakkad

688561

Project Site Office, Hospital of Integrated Research Site HIRS(New), Karoor, Ambalapuzha-PO, Alleppey-District, Kerala, India 688561, Alappuzha

All Listed Sponsors
lead

Traditional Alternative Medicine Research, India

OTHER

NCT01349062 - Traditional Complementary and Alternative Medicine (CAM) Therapy in the Treatment of HIV/AIDS | Biotech Hunter | Biotech Hunter